{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:39:29Z","timestamp":1770817169423,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Cancer Institute","award":["1R21CA267302-01"],"award-info":[{"award-number":["1R21CA267302-01"]}]},{"name":"National Cancer Institute","award":["1R21CA267302-01"],"award-info":[{"award-number":["1R21CA267302-01"]}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["5U54GM104942-04"],"award-info":[{"award-number":["5U54GM104942-04"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36657-1","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:04:45Z","timestamp":1768975485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Application of group A streptococcal collagen-like protein 1-expressing Lactococcus as a novel immunotherapeutic against pancreatic ductal adenocarcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Emily A.","family":"Godfrey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Jeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Sestito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy W.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5159-1838","authenticated-orcid":false,"given":"Slawomir","family":"Lukomski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9006-059X","authenticated-orcid":false,"given":"Brian A.","family":"Boone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"36657_CR1","unstructured":"SEER [Internet]. [cited 2023 Nov 9]. Cancer of the Pancreas - Cancer Stat Facts. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/pancreas.html"},{"issue":"1","key":"36657_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41698-024-00681-z","volume":"8","author":"Y Ju","year":"2024","unstructured":"Ju, Y. et al. Barriers and opportunities in pancreatic cancer immunotherapy. Npj Precis Oncol. 8(1), 199 (2024).","journal-title":"Npj Precis Oncol."},{"issue":"1","key":"36657_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41698-024-00586-x","volume":"8","author":"Y Fu","year":"2024","unstructured":"Fu, Y. et al. Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer. NPJ Precis Oncol. 8 (1), 109 (2024).","journal-title":"NPJ Precis Oncol."},{"issue":"9","key":"36657_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1605822","volume":"8","author":"JL Miller-Ocuin","year":"2019","unstructured":"Miller-Ocuin, J. L. et al. DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth. Oncoimmunology 8(9), e1605822 (2019).","journal-title":"Oncoimmunology"},{"key":"36657_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785222","author":"C Kaltenmeier","year":"2021","unstructured":"Kaltenmeier, C. et al. Neutrophil extracellular traps promote T cell exhaustion in the tumor microenvironment. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.785222 (2021).","journal-title":"Front. Immunol."},{"key":"36657_CR6","unstructured":"Newberger, R., & Gupta, V. Streptococcus Group A. In: StatPearls [Internet]. (StatPearls Publishing, 2024). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559240\/"},{"key":"36657_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1363962\/full","author":"EA Henderson","year":"2024","unstructured":"Henderson, E. A. et al. Group A streptococcal collagen-like protein 1 restricts tumor growth in murine pancreatic adenocarcinoma and inhibits cancer-promoting neutrophil extracellular traps. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1363962\/full (2024).","journal-title":"Front Immunol."},{"issue":"8","key":"36657_CR8","first-page":"704","volume":"31","author":"M Linnebacher","year":"2008","unstructured":"Linnebacher, M., Maletzki, C., Emmrich, J. & Kreikemeyer, B. Lysates of S. pyogenes serotype M49 induce pancreatic tumor growth delay by specific and unspecific antitumor immune responses. J. Immunother Hagerstown Md. 1997. 31 (8), 704\u2013713 (2008).","journal-title":"J. Immunother Hagerstown Md. 1997"},{"issue":"4","key":"36657_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/gut.2007.125419","volume":"57","author":"C Maletzki","year":"2008","unstructured":"Maletzki, C., Linnebacher, M., Kreikemeyer, B. & Emmrich, J. Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model. Gut 57 (4), 483\u2013491 (2008).","journal-title":"Gut"},{"issue":"3","key":"36657_CR10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/mmi.14317","volume":"112","author":"DH McNitt","year":"2019","unstructured":"McNitt, D. H. et al. Adaptation of the group A Streptococcus adhesin Scl1 to bind fibronectin type III repeats within wound-associated extracellular matrix: implications for cancer therapy. Mol. Microbiol. 112(3), 800\u2013819 (2019).","journal-title":"Mol. Microbiol."},{"issue":"20","key":"36657_CR11","doi-asserted-by":"publisher","first-page":"7796","DOI":"10.1074\/jbc.RA118.002250","volume":"293","author":"DH McNitt","year":"2018","unstructured":"McNitt, D. H. et al. Surface-exposed loops and an acidic patch in the Scl1 protein of group A Streptococcus enable Scl1 binding to wound-associated fibronectin. J. Biol. Chem. 293 (20), 7796\u20137810 (2018).","journal-title":"J. Biol. Chem."},{"issue":"10","key":"36657_CR12","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1128\/IAI.01921-14","volume":"82","author":"S D\u00f6hrmann","year":"2014","unstructured":"D\u00f6hrmann, S. et al. Role for Streptococcal Collagen-Like protein 1 in M1T1 group A Streptococcus resistance to neutrophil extracellular traps. Infect. Immun. 82 (10), 4011\u20134020 (2014).","journal-title":"Infect. Immun."},{"issue":"3","key":"36657_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.celrep.2014.06.044","volume":"8","author":"KD Metzler","year":"2014","unstructured":"Metzler, K. D., Goosmann, C., Lubojemska, A., Zychlinsky, A. & Papayannopoulos, V. A Myeloperoxidase-Containing complex regulates neutrophil elastase release and actin dynamics during NETosis. Cell. Rep. 8 (3), 883\u2013896 (2014).","journal-title":"Cell. Rep."},{"key":"36657_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1217095","author":"EA Henderson","year":"2023","unstructured":"Henderson, E. A., Lukomski, S. & Boone, B. A. Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2023.1217095 (2023).","journal-title":"Front Oncol."},{"key":"36657_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.1026248\/full","author":"S Liang","year":"2022","unstructured":"Liang, S. et al. Recent advances in bacteria-mediated cancer therapy. Front. Bioeng. Biotechnol. https:\/\/doi.org\/10.3389\/fbioe.2022.1026248\/full (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"36657_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40425-019-0601-5","volume":"7","author":"VM Kim","year":"2019","unstructured":"Kim, V. M. et al. Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies. J. Immunother Cancer. 7, 132 (2019).","journal-title":"J. Immunother Cancer"},{"issue":"637","key":"36657_CR17","doi-asserted-by":"publisher","first-page":"eabc1600","DOI":"10.1126\/scitranslmed.abc1600","volume":"14","author":"BC Selvanesan","year":"2022","unstructured":"Selvanesan, B. C. et al. Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice. Sci. Transl Med. 14 (637), eabc1600 (2022).","journal-title":"Sci. Transl Med."},{"issue":"2","key":"36657_CR18","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.ymthe.2021.08.023","volume":"30","author":"W Tan","year":"2022","unstructured":"Tan, W. et al. Targeting of pancreatic cancer cells and stromal cells using engineered oncolytic Salmonella typhimurium. Mol. Ther. 30 (2), 662\u2013671 (2022).","journal-title":"Mol. Ther."},{"key":"36657_CR19","unstructured":"Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM). Safety and Efficacy of Lactococcus Lactis Probiotic Bacteria for the Treatment of Chronic Rhinosinusitis[Internet]. clinicaltrials.gov (2019). Report No.: NCT04048174. https:\/\/clinicaltrials.gov\/study\/NCT04048174."},{"key":"36657_CR20","unstructured":"Medical University of Warsaw. An Attempt to Optimize the Results of Liver Transplantation With Administration of Probiotics. [Internet]. clinicaltrials.gov; 2016. Report No.: NCT01735591.\u00a0https:\/\/clinicaltrials.gov\/study\/NCT01735591"},{"issue":"1","key":"36657_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00125-023-06014-2","volume":"67","author":"C Mathieu","year":"2024","unstructured":"Mathieu, C. et al. A first-in-human, open-label phase 1b and a randomised, double-blind phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab. Diabetologia 67 (1), 27\u201341 (2024).","journal-title":"Diabetologia"},{"issue":"12","key":"36657_CR22","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1084\/jem.20142162","volume":"212","author":"CP Zambirinis","year":"2015","unstructured":"Zambirinis, C. P. et al. TLR9 ligation in pancreatic stellate cells promotes tumorigenesis. J. Exp. Med. 212 (12), 2077\u20132094 (2015).","journal-title":"J. Exp. Med."},{"issue":"3","key":"36657_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3109\/03009734.2015.1032453","volume":"120","author":"G Zang","year":"2015","unstructured":"Zang, G. et al. Activated pancreatic stellate cells can impair pancreatic islet function in mice. Ups J. Med. Sci. 120 (3), 169\u2013180 (2015).","journal-title":"Ups J. Med. Sci."},{"issue":"1","key":"36657_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/gut.43.1.128","volume":"43","author":"M Apte","year":"1998","unstructured":"Apte, M. et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 43(1), 128\u2013133 (1998).","journal-title":"Gut"},{"issue":"5","key":"36657_CR25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","volume":"112","author":"T Cramer","year":"2003","unstructured":"Cramer, T. et al. HIF-1\u03b1 is essential for myeloid Cell-Mediated inflammation. Cell 112 (5), 645\u2013657 (2003).","journal-title":"Cell"},{"key":"36657_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1385\/0-89603-310-4:195","volume-title":"Electroporation Protocols for Microorganisms","author":"H Holo","year":"1995","unstructured":"Holo, H. & Nes, I. F. Transformation of Lactococcus by Electroporation. In Electroporation Protocols for Microorganisms (ed. Nickoloff, J. A.) 195\u20139 (Humana Press, 1995). https:\/\/doi.org\/10.1385\/0-89603-310-4:195."},{"key":"36657_CR27","first-page":"3.20.1","volume":"110","author":"M Swamydas","year":"2015","unstructured":"Swamydas, M., Luo, Y., Dorf, M. E. & Lionakis, M. S. Isolation of mouse neutrophils. Curr Protoc Immunol Ed John E Coligan Al. 110, 3.20.1-3.20.15 (2015).","journal-title":"Curr Protoc Immunol Ed John E Coligan Al."},{"issue":"6","key":"36657_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/cgt.2015.21","volume":"22","author":"BA Boone","year":"2015","unstructured":"Boone, B. A. et al. The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer. Cancer Gene Ther. 22(6), 326\u2013334 (2015).","journal-title":"Cancer Gene Ther."},{"issue":"4","key":"36657_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nm.1886","volume":"15","author":"S Gross","year":"2009","unstructured":"Gross, S. et al. Bioluminescence imaging of myeloperoxidase activity in vivo. Nat. Med. 15 (4), 455\u2013461 (2009).","journal-title":"Nat. Med."},{"issue":"2","key":"36657_CR30","doi-asserted-by":"publisher","first-page":"e005837","DOI":"10.1136\/jitc-2022-005837","volume":"11","author":"TW Liu","year":"2023","unstructured":"Liu, T. W. et al. Inhibition of myeloperoxidase enhances immune checkpoint therapy for melanoma. J. Immunother Cancer. 11 (2), e005837 (2023).","journal-title":"J. Immunother Cancer"},{"issue":"1","key":"36657_CR31","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/cpcb.2","volume":"71","author":"J Franco-Barraza","year":"2016","unstructured":"Franco-Barraza, J., Beacham, D. A., Amatangelo, M. D. & Cukierman, E. Preparation of extracellular matrices produced by cultured and primary fibroblasts. Curr Protoc Cell Biol. 71(1), 1091\u201310934 (2016).","journal-title":"Curr Protoc Cell Biol."},{"issue":"12","key":"36657_CR32","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.3390\/cancers13123004","volume":"15","author":"K Kaczmarek","year":"2021","unstructured":"Kaczmarek, K., Wi\u0119ckiewicz, J., W\u0119glarczyk, K., Siedlar, M. & Baran, J. The anti-tumor effect of Lactococcus lactis bacteria-secreting human soluble TRAIL can be enhanced by metformin both in vitro and in vivo in a mouse model of human colorectal cancer. Cancers 15(12), 3004 (2021).","journal-title":"Cancers"},{"key":"36657_CR33","doi-asserted-by":"publisher","first-page":"1157544","DOI":"10.3389\/fmicb.2023.1157544","volume":"14","author":"MF Am\u00e9rico","year":"2023","unstructured":"Am\u00e9rico, M. F. et al. Growth differentiation factor 11 delivered by dairy Lactococcus lactis strains modulates inflammation and prevents mucosal damage in a mice model of intestinal mucositis. Front. Microbiol. 14, 1157544 (2023).","journal-title":"Front. Microbiol."},{"key":"36657_CR34","doi-asserted-by":"publisher","first-page":"108631","DOI":"10.1016\/j.pharmthera.2024.108631","volume":"257","author":"SM Stribbling","year":"2024","unstructured":"Stribbling, S. M., Beach, C. & Ryan, A. J. Orthotopic and metastatic tumour models in preclinical cancer research. Pharmacol. Ther. 257, 108631 (2024).","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"36657_CR35","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1128\/aem.61.7.2771-2774.1995","volume":"61","author":"N Klijn","year":"1995","unstructured":"Klijn, N., Weerkamp, A. H. & de Vos, W. M. Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl. Environ. Microbiol. 61(7), 2771\u20132774 (1995).","journal-title":"Appl. Environ. Microbiol."},{"issue":"3","key":"36657_CR36","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1021\/acsnano.1c09818","volume":"16","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Intravenous delivery of living Listeria monocytogenes elicits Gasdmermin-Dependent tumor pyroptosis and motivates Anti-Tumor immune response. ACS Nano. 16 (3), 4102\u20134115 (2022).","journal-title":"ACS Nano"},{"issue":"12","key":"36657_CR37","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1038\/s44321-024-00159-2","volume":"16","author":"A Copland","year":"2024","unstructured":"Copland, A. et al. Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity. EMBO Mol. Med. 16 (12), 3057\u20133088 (2024).","journal-title":"EMBO Mol. Med."},{"key":"36657_CR38","doi-asserted-by":"publisher","first-page":"14105","DOI":"10.1038\/ncomms14105","volume":"8","author":"S Gopal","year":"2017","unstructured":"Gopal, S. et al. Fibronectin-guided migration of carcinoma collectives. Nat. Commun. 8, 14105 (2017).","journal-title":"Nat. Commun."},{"issue":"8","key":"36657_CR39","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1002\/j.1460-2075.1987.tb02509.x","volume":"6","author":"L Zardi","year":"1987","unstructured":"Zardi, L. et al. Transformed human cells produce a new fibronectin isoform by Preferential alternative splicing of a previously unobserved exon. EMBO J. 6 (8), 2337\u20132342 (1987).","journal-title":"EMBO J."},{"issue":"2","key":"36657_CR40","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1083\/jcb.109.2.903","volume":"109","author":"C Ffrench-Constant","year":"1989","unstructured":"Ffrench-Constant, C., Van de Water, L., Dvorak, H. F. & Hynes, R. O. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J. Cell. Biol. 109 (2), 903\u2013914 (1989).","journal-title":"J. Cell. Biol."},{"issue":"2","key":"36657_CR41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3748\/wjg.v13.i2.236","volume":"13","author":"B Foligne","year":"2007","unstructured":"Foligne, B. et al. Correlation between in vitro and in vivo Immunomodulatory properties of lactic acid bacteria. World J. Gastroenterol. WJG. 13 (2), 236\u2013243 (2007).","journal-title":"World J. Gastroenterol. WJG"},{"key":"36657_CR42","doi-asserted-by":"crossref","unstructured":"Seifert, L. et al. LAG-3-expressing tumor-infiltrating T cells are associated with reduced disease-free survival in pancreatic cancer. Cancers 13(6) (2021).\u00a0https:\/\/www.mdpi.com\/2072-6694\/13\/6\/1297","DOI":"10.3390\/cancers13061297"},{"issue":"5","key":"36657_CR43","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.immuni.2020.03.001","volume":"52","author":"\u00c1 Teijeira","year":"2020","unstructured":"Teijeira, \u00c1. et al. CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity. Immunity 52 (5), 856\u2013871e8 (2020).","journal-title":"Immunity"},{"issue":"12","key":"36657_CR44","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1111\/jcmm.16555","volume":"25","author":"W Jin","year":"2021","unstructured":"Jin, W. et al. Neutrophil extracellular DNA traps promote pancreatic cancer cells migration and invasion by activating EGFR\/ERK pathway. J. Cell. Mol. Med. 25(12), 5443\u20135456 (2021).","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"36657_CR45","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.3390\/ijms25052854","volume":"25","author":"B Varzaru","year":"2024","unstructured":"Varzaru, B. et al. Prognostic value of Circulating Cell-Free DNA concentration and Neutrophil-to-Lymphocyte ratio in patients with pancreatic ductal adenocarcinoma: A prospective cohort study. Int. J. Mol. Sci. 25 (5), 2854 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"36657_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.688377","author":"DR Principe","year":"2021","unstructured":"Principe, D. R. et al. The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.688377 (2021).","journal-title":"Front Oncol."},{"issue":"39","key":"36657_CR47","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.3748\/wjg.v27.i39.6527","volume":"27","author":"A Jain","year":"2021","unstructured":"Jain, A. & Bhardwaj, V. Therapeutic resistance in pancreatic ductal adenocarcinoma: current challenges and future opportunities. World J. Gastroenterol. 27 (39), 6527\u20136550 (2021).","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"36657_CR48","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3390\/nu5061869","volume":"5","author":"H Hardy","year":"2013","unstructured":"Hardy, H., Harris, J., Lyon, E., Beal, J. & Foey, A. D. Probiotics, prebiotics and Immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 5 (6), 1869\u20131912 (2013).","journal-title":"Nutrients"},{"issue":"6","key":"36657_CR49","first-page":"1465","volume":"36","author":"S Dasari","year":"2017","unstructured":"Dasari, S., Kathera, C., Janardhan, A., Praveen Kumar, A. & Viswanath, B. Surfacing role of probiotics in cancer prophylaxis and therapy: A systematic review. Clin. Nutr. Edinb. Scotl. 36 (6), 1465\u20131472 (2017).","journal-title":"Clin. Nutr. Edinb. Scotl."},{"issue":"6","key":"36657_CR50","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/SHK.0000000000000042","volume":"40","author":"JK Bohannon","year":"2013","unstructured":"Bohannon, J. K., Hernandez, A., Enkhbaatar, P., Adams, W. L. & Sherwood, E. R. The immunobiology of TLR4 agonists: from endotoxin tolerance to immunoadjuvants. Shock Augusta Ga. 40 (6), 451\u2013462 (2013).","journal-title":"Shock Augusta Ga."},{"issue":"4","key":"36657_CR51","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.vaccine.2011.11.098","volume":"30","author":"M Bahey-El-Din","year":"2012","unstructured":"Bahey-El-Din, M. Lactococcus lactis-based vaccines from laboratory bench to human use: an overview. Vaccine 30 (4), 685\u2013690 (2012).","journal-title":"Vaccine"},{"issue":"3","key":"36657_CR52","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1574-6968.1994.tb07041.x","volume":"120","author":"PM Norton","year":"1994","unstructured":"Norton, P. M., Brown, H. W. G. & Le Page, R. W. F. The immune response to Lactococcus lactis\u202f: Implications for its use as a vaccine delivery vehicle. FEMS Microbiol. Lett. 120(3), 249\u2013256 (1994).","journal-title":"FEMS Microbiol. Lett."},{"issue":"1","key":"36657_CR53","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cells12010184","volume":"12","author":"C Mazziotta","year":"2023","unstructured":"Mazziotta, C., Tognon, M., Martini, F., Torreggiani, E. & Rotondo, J. C. Probiotics mechanism of action on immune cells and beneficial effects on human health. Cells 12 (1), 184 (2023).","journal-title":"Cells"},{"issue":"5","key":"36657_CR54","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1021\/acs.bioconjchem.9b00161","volume":"30","author":"Z Han","year":"2019","unstructured":"Han, Z. et al. Extradomain-B Fibronectin-Targeted Dextran-Based chemical exchange saturation transfer magnetic resonance imaging probe for detecting pancreatic cancer. Bioconjug. Chem. 30 (5), 1425\u20131433 (2019).","journal-title":"Bioconjug. Chem."},{"key":"36657_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mri.2021.11.008","volume":"86","author":"PL Qiao","year":"2022","unstructured":"Qiao, P. L. et al. Magnetic resonance molecular imaging of extradomain B fibronectin enables detection of pancreatic ductal adenocarcinoma metastasis. Magn. Reson. Imaging. 86, 37\u201345 (2022).","journal-title":"Magn. Reson. Imaging"},{"issue":"1","key":"36657_CR56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/genes11010006","volume":"11","author":"M Ayres Pereira","year":"2019","unstructured":"Ayres Pereira, M. & Chio, I. I. C. Metastasis in pancreatic ductal adenocarcinoma: current standing and methodologies. Genes 11 (1), 6 (2019).","journal-title":"Genes"},{"issue":"4","key":"36657_CR57","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3390\/cancers14040995","volume":"14","author":"M Muller","year":"2022","unstructured":"Muller, M. et al. The immune landscape of human pancreatic ductal carcinoma: key Players, clinical Implications, and challenges. Cancers 14 (4), 995 (2022).","journal-title":"Cancers"},{"issue":"5","key":"36657_CR58","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","volume":"44","author":"AC Anderson","year":"2016","unstructured":"Anderson, A. C., Joller, N., & Kuchroo, V. K. Lag-3, Tim-3, and TIGIT co-inhibitory receptors with specialized functions in immune regulation. Immunity 44 (5), 989\u20131004 (2016).","journal-title":"Immunity"},{"issue":"5663","key":"36657_CR59","first-page":"1532","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann, V. et al. Neutrophil Extracell. Traps Kill Bacteria Sci. ;303(5663):1532\u20131535. (2004).","journal-title":"Neutrophil Extracell. Traps Kill Bacteria Sci."},{"key":"36657_CR60","doi-asserted-by":"crossref","unstructured":"Demkow, U. Molecular mechanisms of neutrophil extracellular trap (NETs) degradation. Int. J. Mol. Sci. 24(5) (2023).\u00a0https:\/\/www.mdpi.com\/1422-0067\/24\/5\/4896","DOI":"10.3390\/ijms24054896"},{"issue":"9","key":"36657_CR61","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1084\/jem.20100239","volume":"207","author":"P Li","year":"2010","unstructured":"Li, P. et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207 (9), 1853\u20131862 (2010).","journal-title":"J. Exp. Med."},{"issue":"7","key":"36657_CR62","doi-asserted-by":"publisher","first-page":"e22043","DOI":"10.1371\/journal.pone.0022043","volume":"11","author":"S Hemmers","year":"2011","unstructured":"Hemmers, S., Teijaro, J. R., Arandjelovic, S. & Mowen, K. A. PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLOS ONE 11(7), e22043 (2011).","journal-title":"PLOS ONE"},{"issue":"2","key":"36657_CR63","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18 (2), 134\u2013147 (2018).","journal-title":"Nat. Rev. Immunol."},{"issue":"17","key":"36657_CR64","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.3390\/cancers13174495","volume":"6","author":"U Demkow","year":"2021","unstructured":"Demkow, U. Neutrophil extracellular traps (NETs) in cancer invasion, evasion and metastasis. Cancers 6(17), 4495 (2021).","journal-title":"Cancers"},{"issue":"23","key":"36657_CR65","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.3390\/cancers13236131","volume":"13","author":"C Kaltenmeier","year":"2021","unstructured":"Kaltenmeier, C., Simmons, R. L., Tohme, S. & Yazdani, H. O. Neutrophil extracellular traps (NETs) in cancer metastasis. Cancers 13 (23), 6131 (2021).","journal-title":"Cancers"},{"issue":"2","key":"36657_CR66","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s42770-023-00928-0","volume":"54","author":"JL Alves","year":"2023","unstructured":"Alves, J. L. et al. Immunomodulatory effects of different strains of Lactococcus lactis in DSS-induced colitis. Braz J. Microbiol. 54 (2), 1203\u20131215 (2023).","journal-title":"Braz J. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36657-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36657-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36657-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T11:04:50Z","timestamp":1770807890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36657-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36657"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36657-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5911"}}